DOJ criminal antitrust probe into Data iSight pricing triggers Claritev premarket plunge
DOJ criminal antitrust probe into Data iSight pricing triggers premarket plunge.
- Reports of a new DOJ criminal price-fixing inquiry into Claritev (formerly MultiPlan) and its Data iSight tool emerged May 14, per Capitol Forum circulation and traders (GuruFocus, multiple wires).
- Investigation focuses on alleged coordination with major insurers to suppress out-of-network reimbursements via algorithmic pricing.
- Escalation from ongoing civil antitrust MDL lawsuits; DOJ filed a statement of interest in 2025 backing providers’ claims of collusion.
- Stock dropped ~15% on May 14 (closed $23.47 after trading as high as ~$28 recently); continued selling drove premarket losses of ~19.5–26% on May 15.
- No other fresh company-specific news (earnings were May 7; recent conference participation and product launch were neutral-to-positive).
- Criminal probe raises heightened legal and business-model risks for the company’s core repricing services.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.